Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre‐existing chronic respiratory disease: Findings of a randomized, open‐label study

BACKGROUND: The efficacy of neuraminidase inhibitors on improvement of respiratory symptoms triggered by influenza in patients with pre‐existing chronic respiratory diseases is unknown. METHODS: This 2‐week, randomized, open‐label study evaluated intravenous peramivir 600 mg on two consecutive days...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Motokazu, Saisho, Yutaka, Tanaka, Hiroshi, Bando, Takuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767948/
https://www.ncbi.nlm.nih.gov/pubmed/32677375
http://dx.doi.org/10.1111/irv.12788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767948/
https://www.ncbi.nlm.nih.gov/pubmed/32677375
http://dx.doi.org/10.1111/irv.12788

Ejemplares similares